Analysis of CMTM6 Expression in Patients With Acute Myeloid Leukemia
NCT05988047 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2024-05-08
Summary
In this study, we aim to investigate the expression of CKLF like MARVEL transmembrane domain containing 6 (CMTM6) in leukemia cells of patients with acute myeloid leukemia (AML). We will use peripheral blood samples and assess CMTM6 expression by flow cytometry and Western Blot.
Conditions
- Acute Myeloid Leukemia, Adult
Sponsors & Collaborators
-
University of Freiburg
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-01
- Primary Completion
- 2024-05-01
- Completion
- 2024-05-01
Countries
- Germany
Study Locations
More Related Trials
-
Evaluating Efficacy and Safety of Flumatinib for Chronic Phase Chronic Myeloid Leukemia(CML-CP) Without Optimal Response (Warning,Failure) to Imatinib or Dasatinib
NCT04681820 ·Status: UNKNOWN
-
A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
NCT05367765 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase
NCT00451035 ·Status: TERMINATED ·Phase: PHASE2
-
IL-6: A Marker for AML Chemo Sensitivity
NCT06486350 ·Status: RECRUITING
-
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
NCT01244750 ·Status: COMPLETED
-
Blood Brain Barrier Penetration and Pharmacokinetics of the Elemene in Malignant Patients.
NCT01679847 ·Status: UNKNOWN
-
Cancer and Immune Cell Metabolism in Patients With Hematological Malignancies
NCT07189117 ·Status: RECRUITING
-
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
NCT06001788 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluation of CD47, "Do Not Eat Me" Signal Expression in Chronic Myeloid Leukemia
NCT06865443 ·Status: NOT_YET_RECRUITING
-
Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia
NCT01057290 ·Status: COMPLETED
-
NAC for Promoting Hematopoietic Recovery in Patients With Acute Myeloid Leukemia After Chemotherapy
NCT06024031 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy Siblings
NCT00897078 ·Status: COMPLETED
-
Incidence and Risk Factors for the Development of Invasive Fungal Infection in Patients Diagnosed With Acute Myeloblastic Leukemia (HIFA)
NCT07060612 ·Status: ACTIVE_NOT_RECRUITING
-
S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia
NCT00899743 ·Status: COMPLETED
-
A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status
NCT00462761 ·Status: COMPLETED ·Phase: PHASE1
-
CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey
NCT03647215 ·Status: COMPLETED
-
A Study to Evaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML) (MK-0482-002)
NCT05038800 ·Status: TERMINATED ·Phase: PHASE1
-
Prospective Investigation of Dynamics of ABL Mutations in Imatinib Failed CML Patients Treated With Nilotinib
NCT01562847 ·Status: UNKNOWN
-
Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
NCT03509896 ·Status: COMPLETED
-
Efficacy, Safety and Long-term Prognosis of Imatinib in Patients Newly Diagnosed With Chronic Myelogenous Leukemia (Chronic Phase)
NCT00237120 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Acute Myeloblastic Leukemia in Younger Patients
NCT00390715 ·Status: COMPLETED
-
S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia
NCT00899171 ·Status: COMPLETED
-
Metabolic Alternation and Clinicohematological Characteristic in Chronic Phase CML in Patient Treated With TKI
NCT06121765 ·Status: NOT_YET_RECRUITING
-
Biomarkers for Personalized Early Assessment of Response During Salvage Chemotherapy in People With Relapsed or Refractory Acute Myeloid Leukemia (PEARL15)
NCT02527447 ·Status: COMPLETED
-
Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan
NCT01464411 ·Status: UNKNOWN